Literature DB >> 26503930

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

Oksana Suchowersky1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26503930     DOI: 10.1038/nrneurol.2015.201

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Authors:  Karl Kieburtz; Barbara C Tilley; Jordan J Elm; Debra Babcock; Robert Hauser; G Webster Ross; Alicia H Augustine; Erika U Augustine; Michael J Aminoff; Ivan G Bodis-Wollner; James Boyd; Franca Cambi; Kelvin Chou; Chadwick W Christine; Michelle Cines; Nabila Dahodwala; Lorelei Derwent; Richard B Dewey; Katherine Hawthorne; David J Houghton; Cornelia Kamp; Maureen Leehey; Mark F Lew; Grace S Lin Liang; Sheng T Luo; Zoltan Mari; John C Morgan; Sotirios Parashos; Adriana Pérez; Helen Petrovitch; Suja Rajan; Sue Reichwein; Jessie Tatsuno Roth; Jay S Schneider; Kathleen M Shannon; David K Simon; Tanya Simuni; Carlos Singer; Lewis Sudarsky; Caroline M Tanner; Chizoba C Umeh; Karen Williams; Anne-Marie Wills
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

Review 2.  Apathy in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Melina G H E den Brok; Jan Willem van Dalen; Willem A van Gool; Eric P Moll van Charante; Rob M A de Bie; Edo Richard
Journal:  Mov Disord       Date:  2015-03-18       Impact factor: 10.338

3.  Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease.

Authors:  Lisa M Stanek; Sergio P Sardi; Bryan Mastis; Amy R Richards; Christopher M Treleaven; Tatyana Taksir; Kuma Misra; Seng H Cheng; Lamya S Shihabuddin
Journal:  Hum Gene Ther       Date:  2014-03-21       Impact factor: 5.695

4.  Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  O Suchowersky; S Reich; J Perlmutter; T Zesiewicz; G Gronseth; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

5.  Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

Authors:  Wilhelmina G Leen; Joerg Klepper; Marcel M Verbeek; Maike Leferink; Tom Hofste; Baziel G van Engelen; Ron A Wevers; Todd Arthur; Nadia Bahi-Buisson; Diana Ballhausen; Jolita Bekhof; Patrick van Bogaert; Inês Carrilho; Brigitte Chabrol; Michael P Champion; James Coldwell; Peter Clayton; Elizabeth Donner; Athanasios Evangeliou; Friedrich Ebinger; Kevin Farrell; Rob J Forsyth; Christian G E L de Goede; Stephanie Gross; Stephanie Grunewald; Hans Holthausen; Sandeep Jayawant; Katherine Lachlan; Vincent Laugel; Kathy Leppig; Ming J Lim; Grazia Mancini; Adela Della Marina; Loreto Martorell; Joe McMenamin; Marije E C Meuwissen; Helen Mundy; Nils O Nilsson; Axel Panzer; Bwee T Poll-The; Christian Rauscher; Christophe M R Rouselle; Inger Sandvig; Thomas Scheffner; Eamonn Sheridan; Neil Simpson; Parol Sykora; Richard Tomlinson; John Trounce; David Webb; Bernhard Weschke; Hans Scheffer; Michél A Willemsen
Journal:  Brain       Date:  2010-02-02       Impact factor: 13.501

6.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Authors:  Paolo Barone; Angelo Antonini; Carlo Colosimo; Roberto Marconi; Letterio Morgante; Tania P Avarello; Eugenio Bottacchi; Antonino Cannas; Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Roberto M Gaglio; Rosa M Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rosanna Scala; Giuseppe Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 7.  Diagnosis and the premotor phase of Parkinson disease.

Authors:  Eduardo Tolosa; Carles Gaig; Joan Santamaría; Yaroslau Compta
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

8.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

9.  Parkinson's disease: From human genetics to clinical trials.

Authors:  Marcel P van der Brug; Andrew Singleton; Thomas Gasser; Patrick A Lewis
Journal:  Sci Transl Med       Date:  2015-09-16       Impact factor: 17.956

10.  The growing spectrum of antibody-associated inflammatory brain diseases in children.

Authors:  Sandra Bigi; Manisha Hladio; Marinka Twilt; Josep Dalmau; Susanne M Benseler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-04-02
  10 in total
  1 in total

1.  Exploring Neural Substrates Underlying the Execution of Behavior Across the Whole Brain.

Authors:  Yuanyuan Yao
Journal:  Neurosci Bull       Date:  2016-09-02       Impact factor: 5.203

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.